|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
US6429213B1
(en)
|
1998-06-17 |
2002-08-06 |
Bristol Myers Squibb Pharma Co |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
EE200100558A
(et)
|
1999-04-28 |
2002-12-16 |
Aventis Pharma Deutschland Gmbh |
Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
US6884593B1
(en)
|
1999-08-23 |
2005-04-26 |
Bml, Inc. |
Method of identifying properties of substance with respect to human prostaglandin D2 receptors
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
WO2002094830A2
(en)
|
2001-05-23 |
2002-11-28 |
Merck Frosst Canada & Co. |
DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
|
|
WO2003006011A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
AU2002336532C1
(en)
*
|
2001-09-14 |
2008-10-16 |
Amgen, Inc |
Linked biaryl compounds
|
|
DE60334015D1
(de)
|
2002-10-30 |
2010-10-14 |
Merck Frosst Canada Ltd |
Pyridopyrrolizin- und pyridoindolizinderivate
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
ES2401079T3
(es)
|
2002-12-20 |
2013-04-16 |
Amgen Inc. |
Moduladores del asma y de la inflamación alérgica
|
|
ES2257616T3
(es)
|
2003-04-25 |
2006-08-01 |
Actimis Pharmaceuticals, Inc. |
Derivados del acido pirimidinilacetico utiles para el tratamiento de enfermedades mediadas por crth2.
|
|
BRPI0415437A
(pt)
|
2003-10-14 |
2006-12-05 |
Oxagen Ltd |
composto, processo para a preparação e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, produto
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
JP4922615B2
(ja)
|
2003-11-26 |
2012-04-25 |
武田薬品工業株式会社 |
受容体機能調節剤
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
JP4922924B2
(ja)
|
2004-04-13 |
2012-04-25 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｃｅｔｐ阻害薬
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006018325A1
(en)
|
2004-08-17 |
2006-02-23 |
Galderma Research & Development, S.N.C. |
Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions
|
|
CN101124207A
(zh)
|
2004-09-21 |
2008-02-13 |
阿特西斯公司 |
显示出crth2受体拮抗作用的苯并咪唑乙酸类和其用途
|
|
AU2005286718A1
(en)
|
2004-09-21 |
2006-03-30 |
Wyeth |
Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
CA2589322A1
(en)
|
2004-11-23 |
2006-06-01 |
Pfizer Products Inc. |
Dibenzyl amine compounds and derivatives
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
RU2405770C2
(ru)
|
2005-09-27 |
2010-12-10 |
Сионоги Энд Ко., Лтд. |
Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
|
|
JP5155171B2
(ja)
|
2005-10-06 |
2013-02-27 |
アストラゼネカ・アクチエボラーグ |
新規化合物
|
|
EP1963259B1
(en)
|
2005-12-15 |
2012-02-15 |
AstraZeneca AB |
Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
|
|
EP3205644A1
(en)
|
2005-12-29 |
2017-08-16 |
Celtaxsys Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
MX2008015638A
(es)
*
|
2006-06-09 |
2009-01-09 |
Icos Corp |
Acidos fenil aceticos sustituidos como antagonistas de dp-2.
|
|
WO2008024746A1
(en)
*
|
2006-08-21 |
2008-02-28 |
Array Biopharma, Inc. |
4-substituted phenoxyphenylacetic acid derivatives
|
|
TW201716375A
(zh)
|
2007-06-12 |
2017-05-16 |
Achaogen Inc |
抗菌劑
|
|
CN101687844B
(zh)
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
|
MX2010003621A
(es)
|
2007-10-01 |
2010-04-14 |
Hoffmann La Roche |
N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
DK2250161T3
(da)
|
2008-01-18 |
2014-01-27 |
Atopix Therapeutics Ltd |
Forbindelser med CRTH2-antagonistaktivitet
|
|
US8168678B2
(en)
|
2008-02-01 |
2012-05-01 |
Panmira Pharmaceuticals, Inc. |
N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
|
|
EP2245002A4
(en)
|
2008-02-01 |
2011-08-17 |
Amira Pharmaceuticals Inc |
AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
EP2268611A2
(en)
*
|
2008-04-02 |
2011-01-05 |
Amira Pharmaceuticals, Inc. |
Aminoalkylphenyl antagonists of prostaglandin d2 receptors
|
|
MX2010014172A
(es)
|
2008-07-03 |
2011-02-22 |
Amira Pharmaceuticals Inc |
Antagonistas de receptores de prostaglandina d2.
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
CA2768492A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Panmira Pharmaceuticals, Llc |
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
|
|
EP2480225A4
(en)
|
2009-07-31 |
2013-05-01 |
Panmira Pharmaceuticals Llc |
DERMAL FORMULATIONS FROM DP2 RECEPTOR ANTAGONISTS
|